Home/Filings/4/0001209191-22-047887
4//SEC Filing

Birznieks Gunther 4

Accession 0001209191-22-047887

CIK 0001347178other

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 5:02 PM ET

Size

6.9 KB

Accession

0001209191-22-047887

Insider Transaction Report

Form 4
Period: 2022-08-26
Birznieks Gunther
SVP, Business Development
Transactions
  • Exercise/Conversion

    Common Stock

    2022-08-26$3.12/sh+1,250$3,900190,057 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2022-08-261,2500 total
    Exercise: $3.12Exp: 2022-12-06Common Stock (1,250 underlying)
Footnotes (1)
  • [F1]The option vested in 48 equal monthly installments beginning on December 7, 2012.

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001702031

Filing Metadata

Form type
4
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 5:02 PM ET
Size
6.9 KB